The CSCs-positive partial EMT CTCs were encountered only in Her2-negative patients and only among non-responders (stable or progressive disease after therapy), revealing that circulating tumor cells that possess both stemness and partial epithelial-to-mesenchymal markers are associated with a lack of response to therapy [18]. The gene discussed is ERBB2; the disease is neoplasm.